You are here

Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
DRUG
CSE Index: 
Currency: 

Bright Minds is a pre-clinical biosciences company with a portfolio of compounds designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. Bright Minds is focused on developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its world class scientific and drug development expertise to bring forward the next generation of safe and efficacious neuropsychiatry drugs into the clinic. Bright Minds drugs extenuate the therapeutic aspects of psychedelic and other serotonergic compounds while minimizing the side effects thereby creating superior drugs to first generation compounds, such as psilocybin. Bright Minds was selected to participate in two National Institutes of Health (“NIH”) Programs. These NIH collaborations are evaluating Bright Minds serotonin agonists for therapeutic potential in pain and in epilepsy.

You are here

Bright Minds Biosciences Inc. (DRUG)

SEDAR Information

Company Info

Address
1500, 1055 West Georgia St.
Vancouver, BC V6E 4N7
Canada
Phone
647-407-2515
Email
ian@brightmindsbio.com
Website
https://brightmindsbio.com
Listing date
Monday, February 8, 2021
Transfer Agent
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
18,710,359
Reserved for Issuance: 
5,191,204

Company Officers

Ian McDonald, CEO
Mark A. Smith, Chief Medical Officer
Ryan Cheung, Chief Financial Officer
Nils Bottler, Director
Jeremy Fryzuk, Director
Jan Torleif Pedersen, Director, Chief Science Officer
David Weiner, Non-Executive Director

Bulletins

05/02/2021

2021-0215 – New Listing - Bright Minds Biosciences Inc. (DRUG)

Le 5 février/February 2021

The common shares of Bright Minds Biosciences Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

TAKESTOCK - Calgary Investor Forum

TAKESTOCK - Calgary Investor Forum

Wednesday, June 7, 2023 -
9:00am to 5:00pm
Summit on Responsible Investment

Summit on Responsible Investment

Tuesday, June 27, 2023 -
9:00am to 7:00pm